About VerImmune
VerImmune is a private company based in Bethesda, Maryland, incorporated in 2019 in Delaware. It has reported $5,875,329 raised in two offerings on Form D since March 2022. Its chief executive is Joshua Wang.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 27, 2024 | Sep 25, 2024 | $4,495,354of $8.0M target | 6 | $749K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 18, 2022 | Mar 31, 2022 | $1,379,975of $2.5M target | 9 | $153K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $5,875,329 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on VerImmune's Form D filed Sep 25, 2024.
CP
Cynthia Poh
Director
KR
Kevin Rongsheng
Director
HS
Haolin Sung
Director
CH
Che Hsu
Director
MN
Marta New
Director
JW
Joshua Wang
Founder, President & CEO, director
RP
Roger Pomerantz
Director
Earlier filings also listed John Troyer (executive officer, last listed Mar 2022).